Transforming Pharma's Commercial Capabilities to Drive Maximum Value

Large pharmaceutical companies need to accelerate their changing competitive strategies, commercial capabilities, and organizational models to respond adequately to new market conditions. To maximize the value of products, consulting firm Booz Allen proposes aligning commercial operations along three distinct businesses, which cut across specialty and primary care segmentation and which are differentiated based on competitive strategies.

By Elizabeth Powers, Charles Beever, Rick Edmunds, and Jay Kumar

The world’s largest pharmaceutical companies are attempting to reposition their go-to-market capabilities in the face of the rapidly changing healthcare industry. The changes they are making are a step in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from In Vivo